|
| Value |
|
Gender, (%) | |
Female | 570 (53.7) |
Male | 491 (46.3) |
Age, | |
Number of patients by age group, (%) | |
65 to 69 years | 246 (23.2) |
70 to 74 years | 284 (26.8) |
75 to 79 years | 233 (22.0) |
>80 years | 298 (28.1) |
Admission department, (%) | |
Gynecology | 33 (3.1) |
Hepatobiliary | 399 (37.6) |
Orthopedics | 154 (14.5) |
Endocrine breast | 8 (0.8) |
Neurosurgery | 13 (1.2) |
Vascular | 454 (42.8) |
ATC codes of drugs causing DRPs | Number of drugs (%) |
A: alimentary tract and metabolism | 337 (31.8) |
A02 drugs for acid-related disorders | 17 (1.6) |
A03 drugs for functional gastrointestinal disorders | 1 (0.1) |
A04 antiemetics and antinauseants | 5 (0.5) |
A05 bile and liver therapy | 41 (3.9) |
A10 drugs used in diabetes | 7 (0.7) |
A12 mineral supplements | 38 (3.6) |
A16 other alimentary tract and metabolism products | 228 (21.5) |
B: blood and blood-forming organs | 238 (22.4) |
B01 antithrombotic agents | 30 (2.8) |
B02 antihemorrhagics | 88 (8.3) |
B03 antianemic preparations | 43 (4.1) |
B05 blood substitutes and perfusion solutions | 77 (7.3) |
C: cardiovascular system | 126 (11.9) |
C01 cardiac therapy | 1 (0.1) |
C02 antihypertensive | 2 (0.2) |
C04 peripheral vasodilators | 109 (10.3) |
C05 vasoprotectives | 13 (1.2) |
C10 lipid-modifying agents | 1 (0.1) |
D: dermatologicals | 1 (0.1) |
D04 antipruritics, incl. antihistamines and anesthetics | 1 (0.1) |
G: genitourinary system and sex hormones | 1 (0.1) |
G04 urologicals | 1 (0.1) |
H: systemic hormonal preparations excl. sex hormones and insulins | 7 (0.7) |
H02 corticosteroids for systemic use | 7 (0.7) |
J: anti-infectives for systemic use | 249 (23.5) |
J01 antibacterials for systemic use | 234 (22.1) |
J04 antimycobacterials | 8 (0.8) |
J05 antivirals for systemic | 7 (0.7) |
L: antineoplasic and immunomodulating agents | 6 (0.6) |
L03 imostimulants | 6 (0.6) |
M: musculoskeletal system | 6 (0.6) |
M01 anti-inflammatory and antirheumatic products | 2 (0.2) |
M05 drugs for treatment of bone diseases | 4 (0.4) |
N: nervous system | 50 (4.7) |
N02 analgesics | 5 (0.5) |
N05 psycholeptics | 4 (0.4) |
N07 other nervous system drugs | 41 (3.9) |
R: respiratory system | 26 (2.5) |
R03 drugs for obstructive airway diseases | 26 (2.5) |
V: various | 14 (1.3) |
V03 all other therapeutic products | 5 (0.5) |
V06 general nutrients | 6 (0.6) |
V08 contrast media | 3 (0.3) |
|